Dubeau L, Jones P A, Rideout W M, Laug W E
Urological Cancer Research Laboratory, University of Southern California, Los Angeles 90033.
Cancer Res. 1988 Oct 1;48(19):5552-6.
The regulation of urokinase (u-PA) and tissue plasminogen activator (t-PA) in cultured normal and neoplastic urothelium was examined because plasminogen activators (PAs) are thought to be important in malignancy. Both activators were synthesized by normal urothelial cells grown in vitro under chemically defined conditions. The level of t-PA activity decreased when normal urothelial cells reached saturation density, but was stimulated more than 10-fold by the addition of epidermal growth factor (EGF) to the culture medium. Northern blot analysis showed that the regulation occurred at the transcriptional level. On the other hand u-PA activity was regulated to a lower degree by EGF and was not affected by cell density. Immunohistochemical examination of urothelial cells in histology specimens showed that t-PA was present only in the apical cells facing the lumen, suggesting that the expression of the activity might be a marker for end-stage differentiation in vivo. In contrast to normal cells, tumor cell lines made only u-PA under all conditions tested, and the levels of its expression were either unaffected or slightly decreased by EGF. Tumor cells and normal cells therefore showed substantial differences in protease regulation by EGF.
由于纤溶酶原激活剂(PAs)被认为在恶性肿瘤中起重要作用,因此研究了培养的正常和肿瘤性尿路上皮中尿激酶(u-PA)和组织型纤溶酶原激活剂(t-PA)的调节情况。在化学定义的条件下体外培养的正常尿路上皮细胞可合成这两种激活剂。当正常尿路上皮细胞达到饱和密度时,t-PA活性水平下降,但向培养基中添加表皮生长因子(EGF)可使其活性提高10倍以上。Northern印迹分析表明,这种调节发生在转录水平。另一方面,u-PA活性受EGF调节的程度较低,且不受细胞密度的影响。组织学标本中尿路上皮细胞的免疫组织化学检查显示,t-PA仅存在于面向管腔的顶端细胞中,这表明该活性的表达可能是体内终末分化的标志物。与正常细胞相反,肿瘤细胞系在所有测试条件下仅产生u-PA,其表达水平不受EGF影响或略有下降。因此,肿瘤细胞和正常细胞在EGF对蛋白酶的调节方面表现出显著差异。